secwatch.observer — SEC 8-K summary
======================================

Issuer:     10x Genomics, Inc. (TXG)
CIK:        0001770787
Form:       8-K
Filed at:   2026-01-12T23:59:59+00:00
Accession:  0001628280-26-001808
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

10x Genomics reports preliminary Q4 rev $166M (+1% YoY); FY 2025 rev $642.8M incl. $44.1M settlements
--------------------------------------------------------------------------------

- Q4 consumables rev $141.7M (+6% YoY); Spatial consumables up 14% YoY to $41.0M.
- Q4 instruments rev $15.5M (-36% YoY); Single Cell instruments down 44% YoY.
- Full year rev ex-settlements $598.7M (-2% YoY); instruments rev down 39%.
- Cash & securities ~$520M at Dec 31, 2025; cumulative instruments: >6,400 Chromium, >1,500 Spatial.
- Single Cell consumables reactions sold increased >20% vs prior year.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1770787/000162828026001808/0001628280-26-001808-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1770787/000162828026001808/txg-20260111.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-001808

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer